Renal and Nonrenal Clearance of Clodronate in Patients with Malignancy and Renal Impairment
- 1 January 1994
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 7 (1), 26-33
- https://doi.org/10.1007/bf03257396
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and HypercalcemiaPublished by Springer Nature ,1989
- A One Year Follow‐Up Study of the Distribution of 14C‐Clodronate in Mice and RatsBasic & Clinical Pharmacology & Toxicology, 1988
- The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myelomaBritish Journal of Haematology, 1983
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- The pathophysiology of hypercaemiaMetabolic Bone Disease and Related Research, 1980
- The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing ratThe Anatomical Record, 1979